Elicitation of immunity to HIV type 1 Gag is determined by Gag structure.
Elicitation of immunity to HIV type 1 Gag is determined by Gag structure.
复制标题
对 HIV 1 型 Gag 的免疫力的引发由 Gag 结构决定。
DOI:
10.1089/aid.2006.22.99
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
Ross,TedM
中科院分区:
文献类型:
--
作者:
Young,KellyR;Ross,TedM
Thegaggene of the human immunodeficiency virus type 1 (HIV-1) encodes for viral proteins that self-assemble into viral particles. The primary Gag gene products (capsid, matrix, and nucleocapsid) elicit humoral and cellular immune responses during natural infection, and these proteins are included in many preclinical and clinical HIV/AIDS vaccines. However, the structure (particulate or soluble) of these proteins may influence the immunity elicited during vaccination. In this study, mice were inoculated with four different HIV-1 Gag vaccines to compare the elicitation of immune responses by the same Gag immunogen presented to the immune system in different forms. The immunity elicited by particles producedin vivoby DNA plasmid (pGag) was compared to these same proteins retained intracellularly (pGagDMyr). In addition, the elicitation of anti- Gag immunity by Gagp55virus-like particles (VLPs) or soluble, nonparticulate Gagp55proteins was compared. Enhanced cellular responses, but almost no anti-Gag antibodies, were elicited with intracellularly retained Gag proteins. In contrast, DNA vaccines expressing VLPs elicited both anti-Gag antibodies and cellular responses. Mice vaccinated with purified Gagp55VLPs elicited robust humoral and cellular immune responses, which were significantly higher than the immunity elicited by soluble, nonparticulate Gagp55protein. Overall, purified particles of Gag effectively elicited the broadest and highest titers of anti-Gag immunity. The structural form of Gag influences the elicited immune responses and should be considered in the design of HIV/AIDS vaccines.